Manson Dean 4
4 · EchoStar CORP · Filed Mar 9, 2026
Research Summary
AI-generated summary of this filing
EchoStar (SATS) CLO Manson Dean Exercises Options, Sells Shares
What Happened
Manson Dean, Chief Legal Officer of EchoStar Corp. (SATS), exercised company stock options and sold most of the resulting shares on March 5, 2026. He exercised 21,631 shares of options at a $14.04 exercise price (cash paid ≈ $303,699). On the same day he sold 7,631 shares at an average price of $114.51 (proceeds ≈ $873,826) and 11,400 shares at an average price of $114.60 (proceeds ≈ $1,306,440), for total cash proceeds of about $2.18 million. The filing also reports two matching derivative conversion/disposition line items at $0.00, which reflect the option-to-stock conversions/settlements disclosed in the Form 4.
Key Details
- Transaction date: March 5, 2026; Form 4 filed March 9, 2026 (appears timely).
- Exercises (code M): 7,631 shares @ $14.04 ($107,139) and 14,000 shares @ $14.04 ($196,560) — total exercised 21,631 shares.
- Open-market sales (code S): 7,631 shares @ avg $114.51 (range $114.31–$114.80 per footnote F1) and 11,400 shares @ avg $114.60 (range $114.33–$114.80 per footnote F2). Total sold ≈ 19,031 shares for ≈ $2.18M.
- Derivative disposals: two M entries showing 7,631 and 14,000 shares disposed at $0.00 (reflecting conversion/settlement of derivatives).
- Shares owned after transaction: not specified in the filing.
- Notable footnotes: F1/F2 show sale price ranges; F3 references a 401(k); F4 and F5 describe vesting schedules for the options underlying the exercised shares.
Context
The sequence — exercising options at the strike price and then selling shares the same day — is commonly a cashless exercise or sell-to-cover pattern used to realize value and cover option cost/taxes. The Form 4 shows both the option exercise (acquisition) and nearly immediate open-market sales (dispositions). These are ordinary insider transactions and do not, by themselves, indicate management sentiment; purchases (cash outflows to acquire stock) tend to be more informative about bullish conviction than routine option exercises followed by sales.
Insider Transaction Report
- Exercise/Conversion
Class A Common Stock
2026-03-05$14.04/sh+7,631$107,139→ 10,029 total - Sale
Class A Common Stock
[F1]2026-03-05$114.51/sh−7,631$873,826→ 2,398 total - Exercise/Conversion
Class A Common Stock
2026-03-05$14.04/sh+14,000$196,560→ 16,398 total - Sale
Class A Common Stock
[F2]2026-03-05$114.60/sh−11,400$1,306,440→ 4,998 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
[F4]2026-03-05−7,631→ 39,700 totalExercise: $14.04Exp: 2034-04-01→ Class A Common Stock (7,631 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
[F5]2026-03-05−14,000→ 42,000 totalExercise: $14.04Exp: 2034-04-01→ Class A Common Stock (14,000 underlying)
- 1,106(indirect: I)
Class A Common Stock
[F3]
Footnotes (5)
- [F1]Based on a weighted average sale price. The shares reported in this transaction were sold at prices ranging from $114.31 to $114.80. Information regarding the number of shares sold at each separate price will be made available upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer.
- [F2]Based on a weighted average sale price. The shares reported in this transaction were sold at prices ranging from $114.33 to $114.80. Information regarding the number of shares sold at each separate price will be made available upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer.
- [F3]By 401(K).
- [F4]40% of the shares underlying these options vested immediately upon the grant date. The remaining 60% of the shares underlying these options vest 30% per year on each of April 1, 2025 and April 1, 2026.
- [F5]The shares underlying these options vest 25% per year on each of April 1, 2025, April 1, 2026, April 1, 2027 and April 1, 2028.